Proof of Concept Study of OC000459 in Eosinophilic Esophagitis

NCT01056783 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Eosinophilic Esophagitis

Interventions

DRUG: OC000459
DRUG: Placebo

Sponsor

Oxagen Ltd